Clear Search

Books+ Search Results

Subject: "Drugs."
Subject (Genre): Is
Is Is Not
Rules and practice
Subject (Region): Is
Is Is Not
United States

Advanced Search

Basic Search
Help
Add a row
Reset

Limit results by

Show Online Results Only
Online Results (86)
1.
Department of Health and Human Services, Food and Drug Administration applications for FDA approval to market a new drug : patent submission and listing requirements and application of a 30-month stays on approval of abbreviated new drug applications certifying that a patent claiming a drug is invalid or will not be infringed
Author
United States. General Accounting Office
Published
Washington, DC : U.S. General Accounting Office, [2003]
Online
http://purl.access.gpo.gov/GPO/LPS37474
Location
Yale Internet Resource
Format
Books / Online
2.
Drug safety FDA has begun efforts to enhance postmarket safety, but additional actions are needed : report to the Ranking Member, Committee on Finance, U.S. Senate
Author
United States. Government Accountability Office
Published
[Washington, D.C.] : U.S. Govt. Accountability Office, [2009]
Online
http://purl.access.gpo.gov/GPO/LPS120216
Location
Yale Internet Resource >> None
Format
Books / Online
3.
Drug safety improvement needed in FDA's postmarket decision-making and oversight process : report to congressional requesters
Author
United States. Government Accountability Office
Published
[Washington, D.C.] : U.S. Government Accountability Office, [2006]
Online
http://purl.access.gpo.gov/GPO/LPS70603
Location
Yale Internet Resource >> None
Format
Books / Online
4.
Prescription drugs FDA's oversight of the promotion of drugs for off-label uses : report to the Ranking Member, Committee on Finance, U.S. Senate
Author
United States. Government Accountability Office
Published
[Washington, D.C.] : U.S. Govt. Accountability Office, [2008]
Online
http://purl.access.gpo.gov/GPO/LPS97939
Location
Yale Internet Resource >> None
Format
Books / Online
5.
Drug Enforcement Administration's regulation of medicine hearing before the Subcommittee on Crime, Terrorism, and Homeland Security of the Committee on the Judiciary, House of Representatives, One Hundred Tenth Congress, first session, July 12, 2007
Author
United States. Congress. House. Committee on the Judiciary. Subcommittee on Crime, Terrorism, and Homeland Security
Published
Washington : U.S. G.P.O., 2008.
Online
http://purl.access.gpo.gov/GPO/LPS96756
Location
Yale Internet Resource >> None
Format
Books / Online
6.
Drug Enforcement Administration's regulation of medicine : hearing before the Subcommittee on Crime, Terrorism, and Homeland Security of the Committee on the Judiciary, House of Representatives, One Hundred Tenth Congress, first session, July 12, 2007
Author
United States. Congress. House. Committee on the Judiciary. Subcommittee on Crime, Terrorism, and Homeland Security
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2008.
Location
Library Shelving Facility (LSF) >> Y 4.J 89/1:110-111
Format
Books
7.
Drug Enforcement Administration's regulation of medicine hearing before the Subcommittee on Crime, Terrorism, and Homeland Security of the Committee on the Judiciary, House of Representatives, One Hundred Tenth Congress, first session, July 12, 2007
Author
United States. Congress. House. Committee on the Judiciary. Subcommittee on Crime, Terrorism, and Homeland Security
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2008.
Online
Online resource
Location
Yale Internet Resource >> None
Format
Books / Online
8.
Generic pharmaceutical patent & FDA law
Online
Access limited to Law School community, contact reference.law@yale.edu; Cover...
Location
Yale Internet Resource
Format
Online
9.
Antibiotics FDA needs to do more to ensure that drug labels contain up-to-date information : report to congressional committees
Author
United States. Government Accountability Office
Published
[Washington, D.C.] : U.S. Govt. Accountability Office, [2012]
Online
http://purl.fdlp.gov/GPO/gpo22379
Location
Yale Internet Resource >> None
Format
Books / Online
10.
Oversight of federal efforts to combat the spread of illicit fentanyl : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, July 16, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations, author
Published
Washington, DC : United States Government Publishing Office, 2021.
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:116-53
Format
Books
11.
Food and Drug Administration's review process for products to treat rare diseases and neglected tropical diseases hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Eleventh Congress, second session, special hearing, June 23, 2010, Washington, D.C.
Author
United States. Congress. Senate. Committee on Appropriations. Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
Published
Washington : U.S. G.P.O., 2011.
Online
http://purl.fdlp.gov/GPO/gpo4112
Location
Yale Internet Resource >> None
Format
Books / Online
12.
Food and Drug Administration's review process for products to treat rare diseases and neglected tropical diseases : hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Eleventh Congress, second session, special hearing, June 23, 2010, Washington, D.C.
Author
United States. Congress. Senate. Committee on Appropriations. Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2011.
Location
Library Shelving Facility (LSF) >> Y 4.AP 6/2:S.HRG.111-841
Format
Books
13.
Drug safety FDA has conducted more foreign inspections and begun to improve its information on foreign establishments, but more progress is needed : report to the Committee on Oversight and Government Reform, House of Representatives
Author
United States. Government Accountability Office
Published
[Washington, D.C.] : U.S. Govt. Accountability Office, [2010]
Online
http://purl.fdlp.gov/GPO/gpo8323
Location
Yale Internet Resource >> None
Format
Books / Online
14.
Food and Drug Administration overseas offices have taken steps to help ensure import safety, but more long-term planning is needed : report to the Committee on Oversight and Government Reform, House of Representatives
Author
United States. Government Accountability Office
Published
[Washington, D.C.] : U.S. Govt. Accountability Office, [2010]
Online
http://purl.fdlp.gov/GPO/gpo8324
Location
Yale Internet Resource >> None
Format
Books / Online
15.
Your guide to reporting problems to FDA
Author
United States. Food and Drug Administration
Published
[Washington, D.C.] : FDA, Consumer Health Information, [2009]
Location
Library Shelving Facility (LSF) >> HE 20.4008:R 29/PACK.
Format
Books
16.
Assessing the safety of our nation's drug supply hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, May 9, 2007
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health
Published
Washington : U.S. G.P.O., 2008.
Online
http://purl.access.gpo.gov/GPO/LPS106452
Location
Yale Internet Resource >> None
Format
Books / Online
17.
Assessing the safety of our nation's drug supply : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, May 9, 2007
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2008.
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:110-43
Format
Books
18.
Assessing the safety of our nation's drug supply hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, May 9, 2007
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2008.
Online
Online resource
Location
Yale Internet Resource >> None
Format
Books / Online
19.
FDA regulatory affairs
Published
Boca Raton, FL : CRC Press, [2014]
Location
Law Library >> RM301.25 .F37X 2014
Format
Books
20.
Food and Drug Administration response to heparin contamination helped protect public health; controls that were needed for working with external entities were recently added : report to the Ranking Member, Committee on Energy and Commerce, House of Representatives
Author
United States. Government Accountability Office
Published
[Washington, D.C.] : U.S. Govt. Accountability Office, [2010]
Online
http://purl.fdlp.gov/GPO/gpo7611
Location
Yale Internet Resource >> None
Format
Books / Online
21.
FDA regulatory affairs : a guide for prescription drugs, medical devices, and biologies
Published
Boca Raton, FL : CRC Press, 2004.
Location
MEDICAL >> RM301.25 F37 2004
Format
Books
22.
Antitrust concerns and the FDA approval process : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fifteenth Congress, first session, July 27, 2017
Author
United States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law, author
Published
Washington : U.S. Government Publishing Office, 2018.
Location
Library Shelving Facility (LSF) >> Y 4.J 89/1:115-27
Format
Books
23.
Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Publishing Office, 2018.
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:115-10
Format
Books
24.
Department of Health and Human Services, Food and Drug Administration bar code label requirement for human drug products and biological products
Author
Wannisky, Kathleen E.
Published
Washington, DC : U.S. General Accounting Office, [2004]
Online
http://purl.access.gpo.gov/GPO/LPS48424
Location
Yale Internet Resource >> None
Format
Books / Online
25.
Is the U.S Department of Veterans Affairs meeting the pharmaceutical needs of veterans? : hearing before the Subcommittee on Health of the Committee on Veterans' Affairs, U.S. House of Representatives, One Hundred Eleventh Congress, first session, September 22, 2009
Author
United States. Congress. House. Committee on Veterans' Affairs. Subcommittee on Health
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2010.
Location
Library Shelving Facility (LSF) >> Y 4.V 64/3:111-42
Format
Books
26.
Is the U.S Department of Veterans Affairs meeting the pharmaceutical needs of veterans? hearing before the Subcommittee on Health of the Committee on Veterans' Affairs, U.S. House of Representatives, One Hundred Eleventh Congress, first session, September 22, 2009
Author
United States. Congress. House. Committee on Veterans' Affairs. Subcommittee on Health
Published
Washington : U.S. G.P.O., 2010.
Online
http://purl.access.gpo.gov/GPO/LPS120904
Location
Yale Internet Resource >> None
Format
Books / Online
27.
Full committee hearing on Medicaid drug reimbursements : are CMS cuts bad medicine for small businesses and beneficiaries?
Author
United States. Congress. House. Committee on Small Business
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2007.
Online
http://purl.access.gpo.gov/GPO/LPS90037
Location
Library Shelving Facility (LSF) >> Y 4.SM 1:110-36
Format
Books
28.
Full committee hearing on Medicaid drug reimbursements are CMS cuts bad medicine for small businesses and beneficiaries?
Author
United States. Congress. House. Committee on Small Business
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2007.
Online
Online resource
Location
Yale Internet Resource >> None
Format
Books / Online
29.
Food and Drug Administration decision process to deny initial application for over-the-counter marketing of the emergency contraceptive drug Plan B was unusual : report to congressional requesters
Author
United States. Government Accountability Office
Published
[Washington, D.C.] : U.S. Government Accountability Office, [2005]
Online
http://purl.access.gpo.gov/GPO/LPS66189
Location
Yale Internet Resource >> None
Format
Books / Online
30.
Prescription drugs FDA has met most performance goals for reviewing applications : report to congressional requesters
Author
United States. Government Accountability Office
Published
[Washington, D.C.] : U.S. Govt. Accountability Office, [2012]
Online
http://purl.fdlp.gov/GPO/gpo25071
Location
Yale Internet Resource >> None
Format
Books / Online
31.
Medical devices FDA review times, 1989 through 1996
Author
United States. General Accounting Office. Health, Education, and Human Services Division
Published
Washington, D.C. : The Office ; Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20884-6015) : The Office, [distributor, 1997]
Online
Search for full text online
Location
Yale Internet Resource >> None
Format
Books / Online
32.
Food and Drug Administration's Critical Path Initiative : hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Tenth Congress, first session, special hearing, June 1, 2007, Salt Lake City, Utah
Author
United States. Congress. Senate. Committee on Appropriations. Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2008.
Online
Text version:
PDF version:
Location
Library Shelving Facility (LSF) >> Y 4.AP 6/2:S.HRG.110-293
Format
Books
33.
Food and Drug Administration's Critical Path Initiative hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Tenth Congress, first session, special hearing, June 1, 2007, Salt Lake City, Utah
Author
United States. Congress. Senate. Committee on Appropriations. Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2008.
Online
Online resource
Location
Yale Internet Resource >> None
Format
Books / Online
34.
Drug control better coordination with the Department of Homeland Security and an updated accountability framework can further enhance DEA's efforts to meet post-9/11 responsibilities : report to the Co-chairman, Caucus on International Narcotics Control, U.S. Senate
Author
United States. Government Accountability Office
Published
[Washington, D.C.] : U.S. Govt. Accountability Office, [2009]
Online
http://purl.access.gpo.gov/GPO/LPS114093
Location
Yale Internet Resource >> None
Format
Books / Online
35.
Overview of Coast Guard drug and migrant interdiction hearing before the Subcommittee on Coast Guard and Maritime Transportation of the Committee on Transportation and Infrastructure, House of Representatives, One Hundred Eleventh Congress, first session, March 11, 2009
Author
United States. Congress. House. Committee on Transportation and Infrastructure. Subcommittee on Coast Guard and Maritime Transportation
Published
Washington : U.S. G.P.O., 2009.
Online
http://purl.access.gpo.gov/GPO/FDLP416
Location
Yale Internet Resource >> None
Format
Books / Online
36.
Overview of Coast Guard drug and migrant interdiction : hearing before the Subcommittee on Coast Guard and Maritime Transportation of the Committee on Transportation and Infrastructure, House of Representatives, One Hundred Eleventh Congress, first session, March 11, 2009
Author
United States. Congress. House. Committee on Transportation and Infrastructure. Subcommittee on Coast Guard and Maritime Transportation
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2009.
Location
Library Shelving Facility (LSF) >> Y 4.T 68/2:111-13
Format
Books
37.
Medicare hospital pharmaceuticals survey shows price variation and highlights data collection lessons and outpatient rate-setting challenges for CMS : report to congressional committees
Author
United States. Government Accountability Office
Published
[Washington, D.C.] : U.S. Government Accountability Office, [2006]
Online
http://purl.access.gpo.gov/GPO/LPS70783
Location
Yale Internet Resource >> None
Format
Books / Online
38.
The Drug Enforcement Administration's role in combating the opioid epidemic : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second session, March 20, 2018
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations, author
Published
Washington : U.S. Government Publishing Office, 2019.
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:115-110
Format
Books
39.
FDA regulatory affairs : a guide for prescription drugs, medical devices, and biologics
Published
New York : Informa Healthcare USA, c2008.
Online
Publisher description
Location
Law Library >> RM301.25 .F37X 2008
Format
Books
40.
Drug control agencies need to plan for likely declines in drug interdiction assets, and develop better performance measures for transit zone operations : report to congressional committees
Author
United States. Government Accountability Office
Published
[Washington, D.C.] : U.S. Government Accountability Office, [2005]
Online
http://purl.access.gpo.gov/GPO/LPS66187
Location
Yale Internet Resource >> None
Format
Books / Online
41.
Medicare comments on CMS proposed 2006 rates for specified covered outpatient drugs and radiopharmaceuticals used in hospitals
Author
Steinwald, Bruce
Published
Washington, DC : U.S. Government Accountability Office, [2005]
Online
http://purl.access.gpo.gov/GPO/LPS65095
Location
Yale Internet Resource >> None
Format
Books / Online
42.
Department of Health and Human Services, Centers for Medicare and Medicaid Services Medicare program : Medicare-endorsed prescription drug card assistance initiative
Author
Wannisky, Kathleen E.
Published
Washington, DC : U.S. General Accounting Office, [2002]
Online
http://purl.access.gpo.gov/GPO/LPS44026
Location
Yale Internet Resource
Format
Books / Online
43.
Adult drug courts studies show courts reduce recidivism, but DOJ could enhance future performance measure revision efforts : report to congressional committees
Author
United States. Government Accountability Office
Published
[Washington, D.C.] : U.S. Govt. Accountability Office, [2011]
Online
http://purl.fdlp.gov/GPO/gpo17345
Location
Yale Internet Resource >> None
Format
Books / Online
44.
The opioid crisis : removing barriers to prevent and treat opioid abuse and dependence in Medicare : hearing before the Subcommittee on Health of the Committee on Ways and Means, U.S. House of Representatives, One Hundred Fifteenth Congress, second session, February 6, 2018
Author
United States. Congress. House. Committee on Ways and Means. Subcommittee on Health, author
Published
Washington : U.S. Government Publishing Office, 2019.
Location
Library Shelving Facility (LSF) >> Y 4.W 36:115-HL 03
Format
Books
45.
Food & Drug Administration guides & manuals
Online
Access limited to Law School community, contact reference.law@yale.edu
Location
Yale Internet Resource
Format
Online
46.
Anti-drug media campaign ONDCP met most mandates, but evaluations of impact are inconclusive : report to Congressional committees
Author
United States. General Accounting Office
Published
Washington, D.C. (P.O. Box 37050, Washington, D.C. 20013) : The Office, [2000]
Online
Search for full text online
Location
Yale Internet Resource >> None
Format
Books / Online
47.
Department of Health and Human Services, Centers for Medicare and Medicaid Services Medicaid program : time limitation on price recalculations and recordkeeping requirements under the drug rebate program
Author
Wannisky, Kathleen E.
Published
Washington, DC : U.S. General Accounting Office, [2003]
Online
http://purl.access.gpo.gov/GPO/LPS38060
Location
Yale Internet Resource
Format
Books / Online
48.
Counternarcotics contracts in Latin America hearing before the Ad Hoc Subcommittee on Contracting Oversight of the Committee on Homeland Security and Governmental Affairs, United States Senate, One Hundred Eleventh Congress, second session, May 20, 2010
Author
United States. Congress. Senate. Committee on Homeland Security and Governmental Affairs. Ad Hoc Subcommittee on Contracting Oversight
Published
Washington : U.S. G.P.O., 2011.
Online
http://purl.fdlp.gov/GPO/gpo8405
Location
Yale Internet Resource >> None
Format
Books / Online
49.
Counternarcotics contracts in Latin America : hearing before the Ad Hoc Subcommittee on Contracting Oversight of the Committee on Homeland Security and Governmental Affairs, United States Senate, One Hundred Eleventh Congress, second session, May 20, 2010
Author
United States. Congress. Senate. Committee on Homeland Security and Governmental Affairs. Ad Hoc Subcommittee on Contracting Oversight
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2011.
Location
Library Shelving Facility (LSF) >> Y 4.G 74/9:S.HRG.111-982
Format
Books
50.
Evidence development participant manual
Published
[Washington, D.C. : Food and Drug Administration, 2003?]
Location
Library Shelving Facility (LSF) >> HE 20.4008:EV 3
Format
Books